AMR101 is a prescription-grade omega-3 fatty acid indicated for the treatment of patients with very high triglyceride levels (>500 mg/dL) and as a potentially first-in-class therapy for patients
The remaining minority share of Ubichem Research remains in the ownership of Jozsef Repasi, managing director of Ubichem Research. Following the acquisition, Ubichem Pharma Services will continue to
Under the agreement, Heptares will make use of its GPCR discovery expertise including StaR technology with Astrazeneca’s biopharmaceutical discovery, development and commercial capabilities. The tie up aims at
Greciet will succeed Dominique Costantini, co-foundator and CEO of BioAlliance Pharma. She is working as the chief operating officer of the company since 1 March 2011. Greciet has
The milestone triggers from the initiation of a Phase I clinical trial of an experimental compound by Boehringer Ingelheim for the treatment neuropathic pain. Previously, Evotec had entered
Lixisenatide, a glucagon-like peptide-1 agonist (GLP-1), is in development for the treatment of patients with type 2 diabetes mellitus. The study showed reduction in HbA1c versus placebo for
Nimotuzumab, a humanized monoclonal antibody targeting EGFR, is indicated for the patients with brain metastasis from non-small cell lung cancer (NSCLC) and palliative treatment of NSCLC. YM BioSciences
RFID Wristbands, known as IC-BANDs, are made of Tyvek material and are available in many colors. RFID Wristbands are used in applications such as cashless payment tracking, tracking
Developed by discovered by D-Pharm, DP-VPA is a drug indicated for the treatment of patients who are suffering from epilepsy, migraine and bipolar disorder. As per the terms
In the trial, the drug was well tolerated at all the doses tested and has demonstrated preliminary evidence of efficacy. The trial investigated the safety, tolerability and efficacy
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.